🇺🇸 Aflibercept Injection in United States

370 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Death — 200 reports (54.05%)
  2. Visual Acuity Reduced — 44 reports (11.89%)
  3. Eye Haemorrhage — 20 reports (5.41%)
  4. Eye Pain — 20 reports (5.41%)
  5. Endophthalmitis — 16 reports (4.32%)
  6. Retinal Haemorrhage — 16 reports (4.32%)
  7. Vision Blurred — 15 reports (4.05%)
  8. Blindness — 14 reports (3.78%)
  9. Non-Infectious Endophthalmitis — 13 reports (3.51%)
  10. Inappropriate Schedule Of Drug Administration — 12 reports (3.24%)

Source database →

Aflibercept Injection in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Aflibercept Injection approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Aflibercept Injection in United States?

Federation Francophone de Cancerologie Digestive is the originator. The local marketing authorisation holder may differ — check the official source linked above.